2257. BDG-Guided Management of Empirical Antifungal Therapy: a Real-life Experience in a Hospital-Wide Context with High Incidence of Non-albicans Candida Infection

BACKGROUND: BDG-guided management of empirical antifungal therapy (AT) has been suggested as a tool to rule out invasive candidiasis (IC) and discontinue AT in critically ill patients. However, some authors reported lower BDG sensibility for non-albicans Candida (NAC) infection. Impact of BDG use in...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconi, Lorenzo, Maccaro, Angelo, Cimatti, Matteo, Scotto, Riccardo, Venturelli, Claudia, Appolloni, Lucia, Furii, Francesca, Morotti, Marta, Puggioli, Cristina, Giannella, Maddalena, Viale, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810797/
http://dx.doi.org/10.1093/ofid/ofz360.1935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810797/
http://dx.doi.org/10.1093/ofid/ofz360.1935

Ejemplares similares